Market Price

73.19 

0.44 0.6%

as of Dec 11 '19

52 Week Range:

43.51 75.07


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

NuVasive, Inc., a medical device company, develops and markets minimally disruptive surgical products and procedurally integrated solutions for spine surgery. Its products focus on applications for spine fusion surgery, including ancillary products and services used to aid in the surgical procedure. The company's principal products include Maximum Access Surgery, a minimally disruptive surgical platform, which includes its software-driven nerve detection and avoidance systems, and intraoperative monitoring (IOM) services and support; MaXcess, an integrated split-blade retractor system; and various specialized implants and biologics. Its spine surgery product line offerings comprise products for the thoracolumbar and the cervical spine, which are primarily used to enable surgeons to access the spine to perform restorative and fusion procedures in a minimally-disruptive fashion. The company's biologics products include Osteocel Plus and Pro, a cellular bone matrix; Formagraft, a collagen-based synthetic bone substitute; AttraX, a synthetic bone graft material; and Propel DBM, a moldable demineralized bone matrix putty and gel. Its IOM services are used for onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also provides implants used for interbody disc height restoration; and fixation products, including pedicle screws, rods, and plates. In addition, it offers Integrated Global Alignment platform for assessing, preserving, and restoring spinal alignment; MAGEC-early onset scoliosis, a spinal bracing and distraction system; and PRECICE, a limb lengthening system. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly-employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was founded in 1997 and is headquartered in San Diego, California.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 5.19
7.64
10.99
10.70
12.31
12.66
13.08
13.87
14.22
14.77
15.59
growth rate 47.2% 43.9% -2.6% 15.1% 2.8% 3.3% 6.0% 2.5% 3.9% 5.6%
Earnings BIT -27.53
6.17
25.91
-100.06
11.26
9.77
72.30
111.01
98.43
120.27
102.35
growth rate 100.0% 319.9% -100.0% 100.0% -13.2% 640.0% 53.5% -11.3% 22.2% -14.9%
Avg.PE -54.70
212.77
14.90
-14.00
217.39
192.31
-56.71
32.04
91.91
41.18
120.80
growth rate 100.0% -93.0% -100.0% 100.0% -11.5% -100.0% 100.0% 186.9% -55.2% 193.4%
ROA -7.72
1.02
10.76
-7.25
0.27
0.67
-1.33
5.04
2.60
5.17
0.75
growth rate 100.0% 954.9% -100.0% 100.0% 148.2% -100.0% 100.0% -48.4% 98.9% -85.5%
ROE -14.33
2.40
21.43
-15.05
0.61
1.39
-2.71
9.93
5.35
11.14
1.53
growth rate 100.0% 792.9% -100.0% 100.0% 127.9% -100.0% 100.0% -46.1% 108.2% -86.3%
ROIC -6.44
2.00
13.80
-7.57
2.16
2.77
0.08
7.99
4.96
8.87
2.82
growth rate 100.0% 590.0% -100.0% 100.0% 28.2% -97.1% 9,887.5% -37.9% 78.8% -68.2%
Cur. Ratio 6.64
5.79
3.41
2.85
3.13
4.58
3.28
7.06
2.37
3.48
3.44
growth rate -12.8% -41.1% -16.4% 9.8% 46.3% -28.4% 115.2% -66.4% 46.8% -1.2%
Quick Ratio 5.05
4.08
2.35
1.92
2.13
3.00
2.24
4.87
1.34
1.69
1.75
growth rate -19.2% -42.4% -18.3% 10.9% 40.9% -25.3% 117.4% -72.5% 26.1% 3.6%
Leverage 2.60
2.20
1.85
2.27
2.16
1.98
2.10
1.86
2.26
2.06
2.05
growth rate -15.4% -15.9% 22.7% -4.9% -8.3% 6.1% -11.4% 21.5% -8.9% -0.5%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 51.60
58.50
76.60
142.29
117.19
141.85
118.96
127.60
171.60
200.22
196.49
growth rate 13.4% 30.9% 85.8% -17.6% 21.0% -16.1% 7.3% 34.5% 16.7% -1.9%
Acct.Payable 73.96
89.96
117.15
13.65
6.79
9.12
4.37
8.80
growth rate 21.6% 30.2% -88.4% -50.2% 34.3% -52.1% 101.5%
Cur.Assets 302.00
317.10
371.80
591.84
513.75
536.01
657.96
702.83
575.44
560.06
618.21
growth rate 5.0% 17.3% 59.2% -13.2% 4.3% 22.8% 6.8% -18.1% -2.7% 10.4%
Total Assets 487.40
652.80
802.00
1,123.56
1,163.79
1,179.57
1,341.57
1,302.67
1,570.80
1,640.14
1,707.86
growth rate 33.9% 22.9% 40.1% 3.6% 1.4% 13.7% -2.9% 20.6% 4.4% 4.1%
Cash 132.30
65.40
92.60
163.49
123.30
102.83
142.39
192.34
153.64
72.80
117.84
growth rate -50.6% 41.6% 76.6% -24.6% -16.6% 38.5% 35.1% -20.1% -52.6% 61.9%
Inventory 68.80
90.20
107.60
119.31
126.36
136.94
154.64
168.14
208.25
247.14
273.24
growth rate 31.1% 19.3% 10.9% 5.9% 8.4% 12.9% 8.7% 23.9% 18.7% 10.6%
Cur.Liabilities 45.50
54.70
109.00
207.38
164.28
117.15
214.10
99.62
242.50
161.40
179.46
growth rate 20.2% 99.3% 90.3% -20.8% -28.7% 82.8% -53.5% 143.4% -33.4% 11.2%
Liabilities 299.80
356.60
367.70
629.52
626.21
583.78
693.21
583.82
870.28
840.72
873.33
growth rate 19.0% 3.1% 71.2% -0.5% -6.8% 18.8% -15.8% 49.1% -3.4% 3.9%
LT Debt 230.00
230.00
230.00
394.02
332.40
346.06
360.75
372.92
564.41
582.92
602.53
growth rate 0.0% 0.0% 71.3% -15.6% 4.1% 4.2% 3.4% 51.4% 3.3% 3.4%
Equity 187.60
296.20
434.40
494.05
537.58
595.79
640.05
711.53
694.94
795.57
834.53
growth rate 57.9% 46.7% 13.7% 8.8% 10.8% 7.4% 11.2% -2.3% 14.5% 4.9%
Common Shares 36.00
39.00
46.00
40.00
44.00
47.00
47.00
52.00
54.00
55.00
52.00
growth rate 8.3% 18.0% -13.0% 10.0% 6.8% 0.0% 10.6% 3.9% 1.9% -5.5%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 39.80
32.90
45.80
53.37
41.19
47.60
58.42
75.77
88.37
110.22
101.92
growth rate -17.3% 39.2% 16.5% -22.8% 15.6% 22.8% 29.7% 16.6% 24.7% -7.5%
Cash Dividends 0.00 0.00 0.00 0.00 0.00
growth rate
Cash From OA -5.00
46.40
65.80
62.97
130.08
97.44
115.55
88.73
158.09
176.97
219.18
growth rate 100.0% 41.8% -4.3% 106.6% -25.1% 18.6% -23.2% 78.2% 12.0% 23.9%
FCF per Share -1.25
0.35
0.44
0.59
2.01
1.25
1.46
-0.67
0.70
1.16
2.13
growth rate 100.0% 25.7% 34.1% 240.7% -37.8% 16.8% -100.0% 100.0% 65.7% 83.6%
Sale Purchase of Stock 54.75
4.88
8.42
23.35
12.11
9.49
9.99
growth rate -91.1% 72.4% 177.3% -48.2% -21.6% 5.3%
FCF -45.00
14.00
20.00
10.00
89.00
50.00
57.00
-19.00
62.00
66.00
110.00
growth rate 100.0% 42.9% -50.0% 790.0% -43.8% 14.0% -100.0% 100.0% 6.5% 66.7%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 250.10
370.30
478.20
540.51
620.26
685.17
762.42
811.11
962.13
1,026.69
1,101.71
growth rate 48.1% 29.1% 13.0% 14.8% 10.5% 11.3% 6.4% 18.6% 6.7% 7.3%
Op.Income -27.90
11.30
32.10
-69.85
3.14
7.90
72.30
111.01
98.43
120.27
102.35
growth rate 100.0% 184.1% -100.0% 100.0% 151.3% 815.0% 53.5% -11.3% 22.2% -14.9%
IBT -27.50
6.20
25.90
-100.06
11.26
9.77
-11.21
112.02
64.78
72.36
8.72
growth rate 100.0% 317.7% -100.0% 100.0% -13.2% -100.0% 100.0% -42.2% 11.7% -88.0%
Net Income -27.50
5.80
78.30
-69.85
3.14
7.90
-16.72
66.29
37.19
81.60
12.48
growth rate 100.0% 1,250.0% -100.0% 100.0% 151.3% -100.0% 100.0% -43.9% 119.4% -84.7%
EPS -0.77
0.15
1.85
-1.73
0.07
0.17
-0.36
1.26
0.69
1.48
0.24
growth rate 100.0% 1,133.3% -100.0% 100.0% 142.9% -100.0% 100.0% -45.2% 114.5% -83.8%
Gross Profit 211.10
309.20
393.10
428.40
466.85
504.69
580.06
616.63
722.03
758.24
790.56
growth rate 46.5% 27.1% 9.0% 9.0% 8.1% 14.9% 6.3% 17.1% 5.0% 4.3%
R&D 25.90
37.60
40.90
38.41
35.30
32.21
37.49
35.83
48.00
50.43
61.70
growth rate 45.2% 8.8% -6.1% -8.1% -8.8% 16.4% -4.4% 34.0% 5.1% 22.4%

Quarterly Statements

Item Name Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Earnings BIT 28.33
29.64
24.01
31.84
30.18
growth rate 4.6% -19.0% 32.7% -5.2%
Balance Sheet Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Acct.Receivable 191.57
196.49
194.36
207.99
203.61
growth rate 2.6% -1.1% 7.0% -2.1%
Acct.Payable 100.91
8.80
99.99
105.71
105.94
growth rate -91.3% 1,036.4% 5.7% 0.2%
Cur.Assets 579.65
618.21
606.33
664.31
710.84
growth rate 6.7% -1.9% 9.6% 7.0%
Total Assets 1,675.40
1,707.86
1,751.10
1,805.31
1,839.85
growth rate 1.9% 2.5% 3.1% 1.9%
Cash 75.11
117.84
93.39
128.38
163.40
growth rate 56.9% -20.8% 37.5% 27.3%
Inventory 271.35
273.24
288.54
297.14
308.89
growth rate 0.7% 5.6% 3.0% 4.0%
Cur.Liabilities 168.24
179.46
161.78
184.64
193.12
growth rate 6.7% -9.9% 14.1% 4.6%
Liabilities 871.78
873.33
911.10
942.59
963.24
growth rate 0.2% 4.3% 3.5% 2.2%
LT Debt 597.52
602.53
607.61
612.76
617.99
growth rate 0.8% 0.8% 0.9% 0.9%
Equity 803.62
834.53
840.01
862.72
876.61
growth rate 3.9% 0.7% 2.7% 1.6%
Common Shares 0.06
0.06
0.06
0.06
0.06
growth rate 0.0% 0.0% 1.6% 0.0%
Cash Flow Statement Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Capital Expenditures 25.02
23.52
33.93
31.46
29.05
growth rate -6.0% 44.3% -7.3% -7.7%
Cash Dividends
growth rate
Cash From OA 73.27
68.69
24.48
68.96
67.15
growth rate -6.3% -64.4% 181.7% -2.6%
Sale Purchase of Stock
growth rate
FCF 48.25
45.18
-9.45
37.50
38.11
growth rate -6.4% -100.0% 100.0% 1.6%
Income Statement Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Sales 271.30
288.33
274.78
292.11
290.84
growth rate 6.3% -4.7% 6.3% -0.4%
Op.Income 28.33
29.64
24.01
31.84
30.18
growth rate 4.6% -19.0% 32.7% -5.2%
IBT 13.31
16.33
10.70
20.88
15.78
growth rate 22.8% -34.5% 95.1% -24.4%
Net Income 15.92
12.16
9.39
14.96
11.01
growth rate -23.7% -22.8% 59.4% -26.4%
EPS
growth rate
Gross Profit 197.14
202.20
200.28
214.53
213.81
growth rate 2.6% -1.0% 7.1% -0.3%
R&D 15.25
17.09
17.58
17.55
18.14
growth rate 12.1% 2.8% -0.1% 3.4%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (59.54)

YOY Growth Grade:

D (49.47)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 81.61 81.41 28.33
EPS / Growth 13.5% 0.90 16.6%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 8.6%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 8.6% 12.9% 12.9%
Future PE 17.20 27.06 27.06
Future EPS 2.05 3.02 3.02
Value Price
MOS %
8.72
-88.1%
20.24
-72.4%
20.24
-72.4%
MOS Price 4.36 10.12 10.12
IRT 24.33 19.21 19.21

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.